In the Viewpoint titled “The Science of Biosimilars—Updating Interchangeability,” published in the October 15, 2024, issue of JAMA, incorrect wording appeared in the first and third paragraphs. In the first sentence of the first paragraph, “Biosimilars Price and Competition” should have read “Biologics Price and Competition.” In the first sentence of the third paragraph, “we recently issued an update to our draft interchangeability guidance” should have read “we recently issued a draft guidance to update our interchangeability guidance.” This article was corrected online.
